LA
TECH icon

Legacy Advisors’s Bio-Techne TECH Stock Holding History

Legacy Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$900K Buy
15,354
+1,075
+8% +$72.8K 0.09% 173
2024
Q4 		$1.03M Buy
14,279
+1,498
+12% +$110K 0.1% 153
2024
Q3 		$1.02M Sell
12,781
-497
-4% -$37.3K 0.11% 144
2024
Q2 		$951K Buy
13,278
+286
+2% +$21K 0.12% 136
2024
Q1 		$915K Buy
12,992
+2,108
+19% +$151K 0.12% 143
2023
Q4 		$840K Buy
10,884
+1,283
+13% +$84.5K 0.11% 148
2023
Q3 		$654K Buy
9,601
+625
+7% +$49.4K 0.11% 162
2023
Q2 		$733K Buy
8,976
+456
+5% +$36.7K 0.11% 143
2023
Q1 		$632K Buy
8,520
+604
+8% +$46.5K 0.12% 128
2022
Q4 		$656K Buy
7,916
+2,496
+46% +$198K 0.12% 121
2022
Q3 		$385K Buy
5,420
+1,340
+33% +$116K 0.09% 147
2022
Q2 		$354K Buy
4,080
+1,352
+50% +$127K 0.07% 152
2022
Q1 		$295K Buy
+2,728
New +$281K 0.06% 168

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Legacy Advisors's TECH Position: Q1 2025 in Review

Legacy Advisors increased its Bio-Techne (TECH) stake by 7.5% in Q1 2025, buying an estimated $72.8K and bringing the position to 15,354 shares worth $900K. The position accounts for 0.09% of the portfolio, ranked #173.

Legacy Advisors first reported a position in TECH in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.03M in Q4 2024. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

  • Legacy Advisors held 15,354 shares of Bio-Techne worth $900K as of Q1 2025.
  • Legacy Advisors bought 1,075 Bio-Techne shares in Q1 2025, an estimated $72.8K.
  • Bio-Techne made up 0.09% of Legacy Advisors's portfolio in Q1 2025, its #173 holding.
  • Legacy Advisors first reported a position in Bio-Techne in Q1 2022 and has held it in 13 quarters since.
  • Legacy Advisors's Bio-Techne position peaked at $1.03M in Q4 2024.
  • 578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.